View ValuationArteris 将来の成長Future 基準チェック /26Arterisは、59.3%と23.2%でそれぞれ年率59.3%で利益と収益が成長すると予測される一方、EPSはgrowで61%年率。主要情報59.3%収益成長率60.97%EPS成長率Software 収益成長19.7%収益成長率23.2%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日13 May 2026今後の成長に関する最新情報お知らせ • Feb 13Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026Arteris, Inc. provided earnings guidance for the first quarter and full year 2026. For the first quarter, the company expects revenue of $20.5 million to $21.5 million. For the year, the company expects revenue of $89.0 million to $93.0 million.分析記事 • Nov 07Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsShareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...お知らせ • Nov 05+ 1 more updateArteris, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Arteris, Inc. provided earnings guidance for the fourth quarter of 2025. For the fourth quarter of 2025, the company expects revenue of $18.4 million to $18.8 million.お知らせ • Aug 07Arteris, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the third quarter and full year 2025. For the quarter, the company expects revenue of $16.8 million to $17.2 million. For the year, the company expects revenue of $66.0 million to $70.0 million.分析記事 • May 15Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...お知らせ • May 15Arteris, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the second quarter and full year 2025. For the quarter, the company expects revenue of $16.1 million to $16.5 million. For the year, the company expects revenue of $65.0 million to $71.0 million.すべての更新を表示Recent updatesお知らせ • May 14+ 1 more updateArteris, Inc. Announces Retirement of Nicholas B. Hawkins as Chief Financial Officer, Effective August 31, 2026Arteris, Inc. announced that on May 8, 2026, Nicholas B. Hawkins, Chief Financial Officer of Arteris, notified Arteris he will retire effective August 31, 2026. Mr. Hawkins will continue to serve as an advisor to the Company after his retirement date to facilitate an orderly transition. Mr. Hawkins’ decision to retire is due to an illness in his family and is not the result of any disagreement with the Company or its independent registered public accountants on any matter relating to the Company’s financial statements, operations, policies or practices. The Board of Directors of Arteris has initiated a comprehensive search for a new CFO.ライブニュース • May 13Arteris Q1 2026 Revenue Tops Estimates With Cycuity Deal and CFO TransitionArteris reported Q1 2026 revenue of US$22.94 million, 39% higher year over year and about 8.7% above consensus estimates. The company closed the acquisition of Cycuity for US$43.1 million, adding hardware security verification software to its portfolio and contributing to integration-related costs in the quarter. Annual contract value and royalties reached a record US$92.8 million, with contracted future revenue of US$84.9 million as of March 31, 2026, while CFO Nicholas B. Hawkins plans to retire on August 31, 2026. This combination of strong reported revenue, record contract value and the Cycuity acquisition indicates a business focused on building a larger, recurring revenue base, alongside some near-term cost pressure from integration. Investors may want to watch how the upcoming CFO transition and the integration of Cycuity affect execution toward the company’s guidance for revenue growth, improved profitability and a move to positive free cash flow in 2026.ナラティブの更新 • May 04AIP: Elevated Future P/E Assumptions Will Likely Constrain Forward Return PotentialAnalysts have increased their price target on Arteris by $0.25 to $20.50 as they refresh their assumptions around the discount rate, profit margin, revenue growth and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the refreshed assumptions on discount rate, profit margin, revenue growth and future P/E expectations as supportive of a higher valuation ceiling, which is reflected in the recent price target updates.ナラティブの更新 • Apr 23Arteris Inc. – Collaboration with MIPS to Accelerate Physical AI SoC Platforms Arteris Inc. has announced a strategic collaboration with MIPS, a subsidiary of GlobalFoundries, to accelerate the development of next-generation system-on-chip (SoC) platforms tailored for physical AI applications.お知らせ • Apr 22+ 1 more updateArteris, Inc., Annual General Meeting, Jun 02, 2026Arteris, Inc., Annual General Meeting, Jun 02, 2026.ナラティブの更新 • Apr 19AIP: Elevated Multiple And Margin Uncertainty Will Constrain AI Era UpsideAnalysts have raised their Arteris price target by $3, citing updated assumptions around discount rates, revenue growth, profit margin, and future P/E that are reflected in the latest valuation model. Analyst Commentary Bearish analysts are treating the higher Arteris price target as a balance between long term potential and near term execution risk.ナラティブの更新 • Apr 05AIP: AI Era Chip Adoption Will Support Continued Fair Value UpsideAnalysts kept their Arteris fair value estimate steady at $24.00, and modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E underpin a slightly refined but unchanged price target view. Analyst Commentary Recent Street research on Arteris points to a cluster of optimistic views, with bullish analysts adjusting price targets and sharpening their focus on the company’s execution and growth potential.ナラティブの更新 • Mar 21AIP: AI Era Chip Demand And Execution Risks Will Shape Balanced OutlookAnalysts have lifted their price target on Arteris to $16.00 from $15.00, citing updated views on revenue growth, profit margins, and future P/E expectations. Analyst Commentary While the latest price target move reflects a more constructive view on Arteris, some bearish analysts are still flagging risks around execution and how the market is pricing the stock.ナラティブの更新 • Mar 07AIP: AI Era Chip Adoption Will Drive Stronger Prospects AheadAnalysts have raised their price target on Arteris from $16.00 to $24.00, citing updated assumptions around revenue growth, profitability, discount rates and future P/E that they believe better reflect the company’s prospects. Analyst Commentary Recent Street research around Arteris highlights a clear tilt toward more optimistic assumptions on the stock, as reflected in higher price targets that analysts view as better aligned with their updated models on revenue, profitability and valuation multiples.ナラティブの更新 • Feb 21AIP: Index Addition And Expanding Design Wins Will Likely Support UpsideAnalysts have raised their Arteris price target by $1 to $20.25, citing updates to revenue growth assumptions, profit margin outlook, discount rate inputs, and future P/E estimates reflected in recent Street research. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the higher price target to $20.25 reflects refreshed assumptions on revenue growth and profitability, which they see as better aligned with recent Street modeling.お知らせ • Feb 13Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026Arteris, Inc. provided earnings guidance for the first quarter and full year 2026. For the first quarter, the company expects revenue of $20.5 million to $21.5 million. For the year, the company expects revenue of $89.0 million to $93.0 million.ナラティブの更新 • Feb 07AIP: Index Inclusion And AI IP Wins Will Support Balanced OutlookAnalysts are keeping their fair value estimate for Arteris steady at $15.00, pointing to small tweaks in assumptions around discount rates, revenue growth, profit margins, and future P/E that fine tune rather than materially shift their outlook. What's in the News Arteris, Inc.分析記事 • Feb 04Arteris, Inc.'s (NASDAQ:AIP) Intrinsic Value Is Potentially 25% Below Its Share PriceKey Insights Using the 2 Stage Free Cash Flow to Equity, Arteris fair value estimate is US$10.94 Arteris is estimated...お知らせ • Feb 03Arteris, Inc. to Report Q4, 2025 Results on Feb 12, 2026Arteris, Inc. announced that they will report Q4, 2025 results After-Market on Feb 12, 2026ナラティブの更新 • Jan 24AIP: Index Inclusion And New Design Wins Will Likely Unlock UpsideAnalysts have raised their fair value estimate for Arteris from US$17.13 to US$19.25, citing updated assumptions on revenue growth, profit margins and future P/E that they view as better aligned with the company’s current risk profile. What's in the News Arteris, Inc.ナラティブの更新 • Jan 17Arteris, Inc. (NASDAQ: AIP) – Acquisition of Cycuity Strengthens Position in Semiconductor Cybersecurity for the AI EraAuthor: Qudus Adebara (Founder of Wane Investment House) Executive Summary Arteris, Inc. (“Arteris” or “the Company”), a leading provider of system IP for accelerating semiconductor development in the AI era, has closed its acquisition of Cycuity, Inc.ナラティブの更新 • Jan 09AIP: Index Addition And AI IP Wins Will Mask Overvaluation RiskAnalysts maintained their fair value estimate for Arteris at $15.00, making only modest adjustments to assumptions on discount rate, revenue growth, profit margin, and future P/E to support this stable price target. What's in the News Arteris, Inc.ナラティブの更新 • Dec 25AIP: Index Addition And AI Deals Will Support Balanced Long-Term OutlookAnalysts have raised their fair value estimate for Arteris from 11.00 dollars to 15.00 dollars, citing slightly stronger long term revenue growth expectations and an increased future earnings multiple, despite a modestly lower profit margin outlook. What's in the News Added to the S&P Software and Services Select Industry Index, increasing visibility among institutional investors (Index Constituent Adds).お知らせ • Dec 13Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million.Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million on December 10, 2025. The consideration of $45 million will be paid as $13.5 million in cash and $19.5 million in shares of Arteris's common stock, par value $0.001 per share. The number of shares to be issued will be based on the volume-weighted average price (VWAP) of the Company’s common stock for the 30 consecutive trading days preceding the second trading day prior to the closing date, subject to a collar mechanism. In addition, there is an Earnout Consideration of up to an additional $12 million payable in shares of the Arteris’s common stock (converted at the VWAP), contingent upon Cycuity achieving certain specified bookings milestones for the 2026 calendar year. Arteris has entered into an Open Market Sale Agreement to offer and sell shares of its common stock, with a par value of $0.001 per share, having an aggregate offering price of up to $75 million. The net proceeds, if any, from these offering are intended to be used for general corporate purposes, including acquisitions or other strategic transactions, including acquisition of Cycuity, Inc. The transaction is subject to the approval of the Merger Agreement by Cycuity’s stockholders and other customary closing conditions. The transaction is expected to close in Arteris’ first quarter of fiscal year 2026. John M. Tolpa of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor for Cycuity, Inc. John A Fisher and Phillip Stoup of Freshfields US LLP acted as legal advisor for Arteris, Inc.お知らせ • Dec 12Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering分析記事 • Dec 12Arteris, Inc. (NASDAQ:AIP) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 27% in the...ナラティブの更新 • Dec 11AIP: Expanded AI Wins Will Likely Fail To Justify Rich ExpectationsAnalysts have modestly raised their price target on Arteris to approximately $17.13 per share. This reflects slightly higher long term margin expectations and a marginally improved growth and risk profile.分析記事 • Nov 29Why Arteris, Inc. (NASDAQ:AIP) Could Be Worth WatchingWhile Arteris, Inc. ( NASDAQ:AIP ) might not have the largest market cap around , it led the NASDAQGM gainers with a...ナラティブの更新 • Nov 27AIP: Major Platform Wins Will Drive Stronger Revenue And Margin UpsideAnalysts have raised their price target for Arteris from $16.75 to $17.13, citing slight improvements in fair value estimates along with modest adjustments in discount rate and profit margin assumptions. What's in the News Blaize adopted Arteris' FlexNoC 5 interconnect IP to enhance the performance and scalability of its programmable AI platform, enabling better energy efficiency and faster time-to-market for edge and cloud AI applications (Client Announcements).Seeking Alpha • Nov 27Arteris: The Hidden Gem Powering The Chiplet RevolutionSummary Arteris is well-positioned in the semiconductor industry, leveraging its FlexNoC 5 and NCore technologies to address chiplet and interconnect complexity. Arteris' strong recurring revenue growth, high gross margins, and recent positive free cash flow signal improving financial health and operational efficiency. Valuation remains attractive, with shares trading below peers and a calculated fair value of $17 per share, offering potential upside from current levels. I rate Arteris stock a buy, recommending a portfolio allocation below 5% due to China exposure and customer concentration risks. Read the full article on Seeking Alphaナラティブの更新 • Nov 12AIP: Revenue Momentum And Client Wins Will Support Balanced OutlookAnalysts have raised their price target for Arteris from $15.00 to $16.75, citing improved revenue growth estimates and slight enhancements to profit margin expectations. What's in the News Blaize has adopted Arteris FlexNoC 5 interconnect IP to enhance the performance and scalability of its AI Platform for hybrid edge and cloud deployments (Client Announcements).分析記事 • Nov 07Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsShareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...お知らせ • Nov 05+ 1 more updateArteris, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Arteris, Inc. provided earnings guidance for the fourth quarter of 2025. For the fourth quarter of 2025, the company expects revenue of $18.4 million to $18.8 million.ナラティブの更新 • Oct 29Broader Partnerships And AI Adoption Will Shape Future Enterprise DemandAnalysts have raised their price target for Arteris by $1, from $14 to $15. They cited adjustments in growth and profitability expectations, despite a modest reduction in projected revenue growth and profit margins.分析記事 • Oct 28Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 48%Arteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...お知らせ • Oct 24Arteris, Inc. to Report Q3, 2025 Results on Nov 04, 2025Arteris, Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025分析記事 • Sep 05Risks Still Elevated At These Prices As Arteris, Inc. (NASDAQ:AIP) Shares Dive 32%The Arteris, Inc. ( NASDAQ:AIP ) share price has softened a substantial 32% over the previous 30 days, handing back...ナラティブの更新 • Aug 08AI And Chiplet Trends Will Expand Enterprise MarketsWith both the discount rate and future P/E multiples remaining virtually unchanged, Arteris’ consensus analyst price target also held steady at $14.00. What's in the News Arteris provided updated revenue guidance for Q3 2025 of $16.8–$17.2 million and full year 2025 of $66.0–$70.0 million.お知らせ • Aug 07Arteris, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the third quarter and full year 2025. For the quarter, the company expects revenue of $16.8 million to $17.2 million. For the year, the company expects revenue of $66.0 million to $70.0 million.分析記事 • Aug 06Estimating The Intrinsic Value Of Arteris, Inc. (NASDAQ:AIP)NasdaqGM:AIP 1 Year Share Price vs Fair Value Explore Arteris's Fair Values from the Community and select yours Key...お知らせ • Jul 24Arteris, Inc. to Report Q2, 2025 Results on Aug 05, 2025Arteris, Inc. announced that they will report Q2, 2025 results on Aug 05, 2025お知らせ • Jun 24Arteris, Inc. Addresses Silicon Design Reuse Challenge with New Magillem Packaging Product for Ip Blocks and ChipletsArteris, Inc. announced the immediate availability of Magillem Packaging, a new software product designed to simplify and speed up the process of building advanced chips used in everything from AI data centers to edge devices. As chip design becomes increasingly complex with more components, higher performance demands and tighter timelines, Magillem Packaging helps engineering teams work faster and more efficiently by automating one of the most time-consuming parts of the design process: assembling and reusing existing technology. Magillem Packaging enables IP teams to quickly and reliably package and prepare hundreds or even thousands of components for integration into a chiplet or SoC, including new, existing or third-party IP blocks. Based on the latest version of the IEEE 1685 (IP-XACT) standard, Magillem Packaging works seamlessly with industry tools and silicon IP, helping companies keep up with increasing design demands while reducing costly errors and delays. Key Capabilities of Magillem Packaging from Arteris: IP Reuse with comprehensive IP, subsystem and chiplet packaging in a reusable format including configuration, implementation and verification for incremental and full packaging with a proven methodology. Correct-by-construction IEEE 1685-2022 generation without requiring any pre- requisite IP-XACT expertise, while standard compliance and data consistency are ensured by construction and assessed with a built-in Magillem checkers suite. Scalable and fully automated generation of IP packaging for both reused and new IP blocks, with support for legacy 2009 and 2014 versions of IEEE 1685 standard, with intuitive graphical editors enabling fast viewing and editing of IP block descriptions. The new software builds on Arteris' proven approach to design automation and complements its broader suite of products used by many of the world's top semiconductor companies.分析記事 • Jun 20Is It Time To Consider Buying Arteris, Inc. (NASDAQ:AIP)?Arteris, Inc. ( NASDAQ:AIP ), might not be a large cap stock, but it led the NASDAQGM gainers with a relatively large...分析記事 • Jun 20Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 25%Arteris, Inc. ( NASDAQ:AIP ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...分析記事 • May 15Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...お知らせ • May 15Arteris, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the second quarter and full year 2025. For the quarter, the company expects revenue of $16.1 million to $16.5 million. For the year, the company expects revenue of $65.0 million to $71.0 million.お知らせ • Apr 25Arteris, Inc., Annual General Meeting, Jun 03, 2025Arteris, Inc., Annual General Meeting, Jun 03, 2025.お知らせ • Apr 24Arteris, Inc. to Report Q1, 2025 Results on May 13, 2025Arteris, Inc. announced that they will report Q1, 2025 results After-Market on May 13, 2025分析記事 • Apr 19Market Cool On Arteris, Inc.'s (NASDAQ:AIP) Revenues Pushing Shares 26% LowerTo the annoyance of some shareholders, Arteris, Inc. ( NASDAQ:AIP ) shares are down a considerable 26% in the last...新しいナラティブ • Mar 28Semiconductor IP And FlexGen Systems Will Expand AI Automotive Markets Growing demand for AI and automotive solutions, alongside strategic microcontroller expansion, is set to drive Arteris' revenue and earnings growth. 分析記事 • Feb 26Some Confidence Is Lacking In Arteris, Inc. (NASDAQ:AIP) As Shares Slide 26%Arteris, Inc. ( NASDAQ:AIP ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...お知らせ • Feb 26Arteris, Inc. Releases the Latest Generation of Magillem Registers to Automate Semiconductor Hardware/Software IntegrationArteris, Inc. announced the immediate availability of the latest generation of Magillem Registers technology for SoC integration automation. This product enables design teams to automate the hardware/software integration process, reducing the development time by 35% when compared to in-house solutions and empowers them to overcome design complexity challenges, freeing up cycles for new innovation.Magillem Registers is a comprehensive register design and management product that accurately automates the hardware/software interface (HSI) to quickly develop chips and chiplets ranging from IoT devices to complex AI datacenter multi-die SoCs. This product empowers chip architects, hardware designers, firmware engineers, verification teams, and documentation teams to overcome complexity and satisfy the need for real-time, effective cross-functional team communication. It mitigates the risk of out-of-date standards with a unified specification and compilation flow to generate accurate designs. Building upon the silicon-proven Magillem 5 and CSRCompiler technologies, the latest release of Magillem Registers is designed to streamline and optimize workflows by providing an integrated, single source of truth infrastructure to specify, document, implement, and verify SoC address maps. This approach boosts productivity by promoting efficient IP reuse and ensuring consistency across the relevant design teams. With over 1,000 semantic and syntactic checks, Magillem Registers ensures high-quality output, validating third-party IPs, in-house IPs, and overall system integration to significantly reduce the risk of silicon failure. Additionally, intelligent automation enables a remarkable 35%-time reduction in HSI development compared to manual solutions, empowering development teams to meet tight deadlines with confidence. The latest release of Magillem Registers brings significant advancements to performance, capacity, standards support, and usability. It delivers up to 3x faster performance compared to Magillem 5, enabling the compilation of million of registers within minutes while auto-generating synthesizable RTL register banks. With a 5x increase in supported design size, it scales seamlessly from small to very large multi-die devices which contain million of control registers. Magillem Registers offers broad support for industry standards, including the addition of IEEE 1685-2022 (IP-XACT) and SystemRDL 2.0, alongside the previous versions. This enhances intellectual property (IP) reuse, and expands compatibility with third-party IP vendors, improving SoC integration. Usability enhancements further boost team productivity with a rapid, highly iterative design environment incorporating features for streamlined input, intuitive document navigation, customizable workflows, and the elimination of repetitive time-consuming and error-prone manual tasks through advanced automation. Magillem Registers addresses the growing demands of modern design environments with unmatched efficiency and scalability.Seeking Alpha • Feb 24Arteris Q4: Long Growth Runway Ahead Overshadowed By The Lack Of ProfitabilitySummary Management has guided for 15% year over year ACV plus Royalties, with corresponding growth in RPO of 22%. While the company, Arteris, remains unprofitable, margins are projected to improve, with positive FCF expected in 2025. At 4.5 times ACV plus Royalties, its valuation represents a significant discount compared to larger peers. Given its higher risk profile, I recommend AIP stock as a speculative Buy. Read the full article on Seeking Alpha分析記事 • Feb 21Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsArteris, Inc. ( NASDAQ:AIP ) came out with its full-year results last week, and we wanted to see how the business is...お知らせ • Feb 19Arteris, Inc. Introduces FlexGen, Revolutionizing Semiconductor Design with Smart Network-on-Chip IPArteris, Inc. introduced FlexGen, a revolutionary, smart network-on-chip (NoC) interconnect IP. FlexGen from Arteris dramatically accelerates chip development while optimizing performance efficiency, addressing the rising demand for faster, more sustainable innovation in automotive, datacenter, consumer electronics, communications and industrial applications. With up to a 10x productivity boost, FlexGen slashes design iterations, significantly reducing the time required to develop cutting-edge chips. FlexGen also achieves up to a 30% reduction in wire length to lower power use, and up to 10% reduction in latency that results in improved performance in SoC and chiplet designs. FlexGen builds upon the silicon-proven and physically aware FlexNoC 5 NoC IP technology and component library to automate the creation of high-performance network-on-chip (NoC) designs. Supported by AI-driven automation, FlexGen reduces manual adjustments by over 90%, enabling the generation of optimized NoC topologies in hours instead of days. This significantly accelerates development while maintaining the quality achieved through manual methods. These advancements are critical as the industry scales to meet the demands of advanced technologies like artificial intelligence, autonomous driving and cloud computing. By streamlining chip design workflows and automating key processes, FlexGen enables companies to tackle the growing complexity of semiconductor design with fewer resources, paving the way for innovations in AI, 5G, and industrial IoT. With FlexGen, Arteris continues to revolutionize SoC and chiplet design automation based on Arm, RISC-V and x86 processors, enhancing productivity and positioning teams to address the complexities of next-generation electronic systems.お知らせ • Feb 03Arteris, Inc. to Report Q4, 2024 Results on Feb 18, 2025Arteris, Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025分析記事 • Dec 28Is Arteris (NASDAQ:AIP) Using Debt Sensibly?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Dec 01Arteris, Inc. (NASDAQ:AIP) Stock Rockets 26% As Investors Are Less Pessimistic Than ExpectedArteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...お知らせ • Nov 06Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2024Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2024. For the quarter, the company expects revenue of $14.7 million - $15.7 million. For the year, the company expects revenue of $56.9 million - $57.9 million.お知らせ • Oct 22Arteris, Inc. to Report Q3, 2024 Results on Nov 05, 2024Arteris, Inc. announced that they will report Q3, 2024 results After-Market on Nov 05, 2024お知らせ • Oct 16Arteris Network-on-Chip Tiling Innovation Accelerates Semiconductor Designs for AI ApplicationsArteris, Inc. announced an innovative evolution of its network-on-chip (NoC) IP products with tiling capabilities and extended mesh topology support for faster development of Artificial Intelligence (AI) and Machine Learning (ML) compute in system-on-chip (SoC) designs. The new functionality enables design teams to scale compute performance by more than 10 times while meeting project schedules plus power, performance and area (PPA) goals. Network-on-chip tiling is an emerging trend in SoC design. The evolutionary approach uses proven, robust network-on-chip IP to facilitate scaling, condense design time, speed testing and reduce design risk. It allows SoC architects to create modular, scalable designs by replicating soft tiles across the chip. Each soft tile represents a self-contained functional unit, enabling faster integration, verification and optimization. Tiling coupled with mesh topologies within Arteris’ NoC IP products, FlexNoC and Ncore, are transformative for the ever-growing inclusion of AI compute into most SoCs. AI-enabled systems are growing in size and complexity yet can be quickly scaled with the addition of soft tiles without disrupting the entire SoC design. Together, the combination of tiling and mesh topologies provides a way to further reduce the auxiliary processing unit (XPU) sub-system design time and overall SoC connectivity execution time by up to 50% versus manually integrated, non-tiled designs. The first iteration of NoC tiling organizes Network Interface Units (NIUs) into modular, repeatable blocks, improving scalability, efficiency and reliability in SoC designs. These SoC designs result in increasingly larger and more advanced AI compute which supports fast-growing, sophisticated AI workloads for Vision, Machine Learning (ML) models, Deep Learning (DL), Natural Language Processing (NLP) including Large Language Models (LLMs), and Generative AI (GAI), both for training and inference, including at the edge. The FlexNoC and Ncore NoC IP products, which offer expanded AI support via tiling and extended mesh topology capabilities, are now available to early-access customers and partners.Seeking Alpha • Oct 13Arteris: Favorable Industry Trends Set To Fuel Growth AheadSummary The company is poised to benefit from industry tailwinds arising from AI and autonomous driving, owing to its strong technology offering. Growth is strong, with the business already generating positive FCF so far this year. I expect mid double-digit growth rates to continue in the coming years, with an inflection to non-GAAP profitability likely next year. While risks are significant, the appealing valuation leads me to rate the shares as a speculative Buy. Read the full article on Seeking Alphaお知らせ • Sep 17Joachim Kunkel Joins Arteris's Board of DirectorsArteris, Inc. announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys’ IP revenue to over $1.5 billion. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where he played a pivotal role in its early success by contributing to engineering, sales and marketing. He holds a master’s degree in electrical engineering from Aachen University of Technology, where he focused his research on system-level simulation techniques for digital signal processing.お知らせ • Aug 02Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Arteris, Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, the company expects revenue of $14.2 million to $15.2 million. For the year, the company expects revenue of $56.0million to $58.0 million.分析記事 • Jul 27What Arteris, Inc.'s (NASDAQ:AIP) 26% Share Price Gain Is Not Telling YouDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 26% in the...お知らせ • Jul 23Arteris, Inc. to Report Q2, 2024 Results on Aug 01, 2024Arteris, Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024分析記事 • May 07Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 32%Arteris, Inc. ( NASDAQ:AIP ) shares have continued their recent momentum with a 32% gain in the last month alone. The...Recent Insider Transactions Derivative • May 06VP, General Counsel & Secretary exercised options and sold US$66k worth of stockOn the 1st of May, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$6.38 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$977k more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • May 03First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: US$0.25 loss per share. Revenue: US$12.9m (down 1.6% from 1Q 2023). Net loss: US$9.40m (loss widened 4.4% from 1Q 2023). Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US.お知らせ • May 03Arteris, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024Arteris, Inc. provided earnings guidance for the Second Quarter and Full Year 2024. For the quarter, the company expected ACV + TTM royalties to be $58.0 million - $62.0 million. Revenue to be $13.2 million - $14.2 million. For the year, the company expected ACV + TTM royalties to be $62.0 million - $68.0 million. Revenue to be $54.5 million - $57.5 million.お知らせ • Apr 24+ 1 more updateArteris, Inc., Annual General Meeting, Jun 04, 2024Arteris, Inc., Annual General Meeting, Jun 04, 2024, at 08:30 Pacific Standard Time. Agenda: To consider election of Class III directors whose current terms will expire at the annual meeting of stockholders to be held in 2024; to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm and independent auditor for the fiscal year ending December 31, 2024; and to consider transact any other business as may properly come before the 2024 Annual Meeting or any adjournments or postponement thereof.Recent Insider Transactions • Apr 07Chairman recently sold US$71k worth of stockOn the 2nd of April, Karel Janac sold around 10k shares on-market at roughly US$7.03 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karel has been a net seller over the last 12 months, reducing personal holdings by US$106k.Recent Insider Transactions Derivative • Apr 05VP, General Counsel & Secretary exercised options and sold US$75k worth of stockOn the 1st of April, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$7.24 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$764k more than they bought, via options and on-market transactions in the last 12 months.お知らせ • Mar 13Arteris Expands Ncore Cache Coherent Interconnect IP to Accelerate Leading-Edge Electronics DesignsArteris, Inc. announced the immediate availability of the latest release of Ncore cache coherent network-on-chip (NoC) IP. Ncore ensures low latency integration of hardware accelerators into a coherent domain, enabling the speed and efficiency required for cutting-edge applications in complex SoC designs. Deploying Ncore can save SoC design teams upwards of 50 years of engineering effort per project compared to manually generated interconnect solutions. The latest release of Ncore works with multiple processor IPs, including RISC-V and the next-generation Armv9 Cortex processor IP. Ncore boasts multi-protocol support, allowing seamless integration of IPs connected to the same NoC fabric. Designers can choose from CHI-E, CHI-B and ACE fully coherent agent interfaces and ACE-Lite IO-coherent interfaces. AXI is also supported for interfacing with sub-systems or devices without coherency requirements. These capabilities enhance the flexibility and adaptability of Ncore, making it an ideal solution for complex and evolving SoC designs, including safety-critical applications. With configurability and scalability at its core, Ncore empowers SoC designers to meet specific power, performance and area requirements with the flexible fine-tuning of the NoC architecture. Ncore is also ISO 26262 certified, helping design teams address the critical demands of automotive and industrial safety applications with requirements from ASIL B to ASIL D. Ncore's ISO 26262 certification underscores Arteris' ongoing commitment to delivering safe, secure and reliable technology to its global customers. Ncore supports direct connections for heterogeneous, asymmetric systems and other flexible connectivity options, ensuring adaptability to various applications across automotive, industrial, communications and enterprise computing markets. Ncore cache coherent interconnect IP is an ideal companion to FlexNoC, Arteris' industry-leading non-coherent interconnect IP.Recent Insider Transactions Derivative • Mar 08VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 12k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of March. If the sale is conducted around the recent share price of US$7.26, it would amount to US$84k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$595k more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Feb 22Full year 2023 earnings: EPS in line with analyst expectations despite revenue beatFull year 2023 results: US$1.03 loss per share (further deteriorated from US$0.84 loss in FY 2022). Revenue: US$53.7m (up 6.5% from FY 2022). Net loss: US$36.9m (loss widened 35% from FY 2022). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US.お知らせ • Feb 21Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024Arteris, Inc. provided earnings guidance for the first quarter and full year of 2024. For the quarter, the company expects revenue of $12.1 million to $13.1 million.For the year, the company expects revenue of $54.5 million to $57.5 million.分析記事 • Feb 09Optimistic Investors Push Arteris, Inc. (NASDAQ:AIP) Shares Up 29% But Growth Is LackingDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 29% in the...Recent Insider Transactions Derivative • Feb 04VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 13k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of February. If the sale is conducted around the recent share price of US$6.19, it would amount to US$82k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$532k more than they bought, via options and on-market transactions in the last 12 months.Board Change • Feb 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent Director Claudia Munce was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 30Arteris, Inc. to Report Q4, 2023 Results on Feb 20, 2024Arteris, Inc. announced that they will report Q4, 2023 results After-Market on Feb 20, 2024Recent Insider Transactions Derivative • Jan 07VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 32k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of January. If the sale is conducted around the recent share price of US$5.41, it would amount to US$174k. Since March 2023, Nicholas' direct individual holding has decreased from 269.10k shares to 189.10k. Company insiders have collectively sold US$427k more than they bought, via options and on-market transactions in the last 12 months.分析記事 • Dec 14Subdued Growth No Barrier To Arteris, Inc. (NASDAQ:AIP) With Shares Advancing 39%Arteris, Inc. ( NASDAQ:AIP ) shareholders are no doubt pleased to see that the share price has bounced 39% in the last...Recent Insider Transactions Derivative • Dec 07VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 21k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of December. If the sale is conducted around the recent share price of US$5.40, it would amount to US$112k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 209.10k. Company insiders have collectively sold US$370k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Nov 26VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of November. If the sale is conducted around the recent share price of US$4.80, it would amount to US$96k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 229.10k. Company insiders have collectively sold US$313k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Nov 18VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 53k shares in the next 90 days after lodging an Intent To Sell Form on the 15th of November. If the sale is conducted around the recent share price of US$4.86, it would amount to US$258k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 43.07k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Nov 10Third quarter 2023 earnings: EPS and revenues exceed analyst expectationsThird quarter 2023 results: US$0.23 loss per share. Revenue: US$13.3m (up 5.4% from 3Q 2022). Net loss: US$8.15m (loss widened 6.1% from 3Q 2022). Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US.分析記事 • Nov 09Downgrade: Here's How Analysts See Arteris, Inc. (NASDAQ:AIP) Performing In The Near TermOne thing we could say about the analysts on Arteris, Inc. ( NASDAQ:AIP ) - they aren't optimistic, having just made a...お知らせ • Nov 09Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2023. For the quarter, the company expected revenue to be in the range of $11.3 million to $12.3 million. For the full year, the company expected revenue to be in the range of $52.5 million to $53.5 million.Price Target Changed • Nov 09Price target decreased by 18% to US$11.50Down from US$14.00, the current price target is an average from 6 analysts. New target price is 138% above last closing price of US$4.83. Stock is up 4.5% over the past year. The company is forecast to post a net loss per share of US$1.07 next year compared to a net loss per share of US$0.84 last year.お知らせ • Oct 25Arteris, Inc. to Report Q3, 2023 Results on Nov 07, 2023Arteris, Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023Recent Insider Transactions Derivative • Oct 06VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 23k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of October. If the sale is conducted around the recent share price of US$6.24, it would amount to US$141k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 249.10k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions Derivative • Sep 11Chief Operating Officer notifies of intention to sell stockLaurent Moll intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of September. If the sale is conducted around the recent share price of US$7.19, it would amount to US$146k. Since December 2022, Laurent's direct individual holding has increased from 77.29k shares to 185.77k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Aug 04Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.18 loss in 2Q 2022). Revenue: US$14.7m (flat on 2Q 2022). Net loss: US$9.17m (loss widened 62% from 2Q 2022). Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) missed analyst estimates by 5.4%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US.お知らせ • Aug 04Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2023Arteris, Inc. provided earnings guidance for the third quarter and full year of 2023. For the quarter, the company expects revenue to be in the range of $12.5 million to $13.5 million.For the full year, the company expects revenue to be in the range of $54.0 million to $56.0 million.お知らせ • Jul 23Arteris, Inc. to Report Q2, 2023 Results on Aug 03, 2023Arteris, Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023Recent Insider Transactions Derivative • Jun 12VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 42k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of June. If the sale is conducted around the recent share price of US$7.44, it would amount to US$313k. Paul now holds 48.95k shares directly in their own name. Company insiders have collectively bought US$49k more than they sold, via options and on-market transactions, in the last 12 months.お知らせ • May 06Arteris, Inc. Provides Earnings Guidance for the Second Quarter of 2023; Provides Earnings Guidance for the Year 2023Arteris, Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expects revenue of $53.5 million to $57.5 million.For the year, the company expects revenue of $60.4 million to $65.4 million.Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.22 loss in 1Q 2022). Revenue: US$13.2m (up 12% from 1Q 2022). Net loss: US$9.01m (loss widened 32% from 1Q 2022). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Software industry in the US.Price Target Changed • Mar 14Price target decreased by 8.1% to US$13.60Down from US$14.80, the current price target is an average from 5 analysts. New target price is 202% above last closing price of US$4.51. Stock is down 65% over the past year. The company is forecast to post a net loss per share of US$0.93 next year compared to a net loss per share of US$0.84 last year.業績と収益の成長予測NasdaqGM:AIP - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281528N/AN/A212/31/2027113-201214412/31/202694-317043/31/202677-35-5-3N/A12/31/202571-3557N/A9/30/202566-3401N/A6/30/202563-33-2-1N/A3/31/202561-3212N/A12/31/202458-34-1-1N/A9/30/202455-36-2-1N/A6/30/202453-36-6-5N/A3/31/202453-37-8-7N/A12/31/202354-37-17-16N/A9/30/202352-34-15-13N/A6/30/202352-33-17-16N/A3/31/202352-30-15-14N/A12/31/202250-27-8-7N/A9/30/202251-28-4-3N/A6/30/202247-25-10N/A3/31/202243-23-4-3N/A12/31/202138-23-2-1N/A9/30/202141-8-2-1N/A6/30/202138-700N/A3/31/202133-622N/A12/31/202032-322N/A12/31/2019325N/A12N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: AIP今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: AIP今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: AIP今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: AIPの収益 ( 23.2% ) US市場 ( 11.7% ) よりも速いペースで成長すると予測されています。高い収益成長: AIPの収益 ( 23.2% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: AIPの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/17 16:13終値2026/05/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Arteris, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Ambrish SrivastavaBMO Capital Markets Equity ResearchBlayne CurtisJefferies LLCMark LipacisJefferies LLC3 その他のアナリストを表示
お知らせ • Feb 13Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026Arteris, Inc. provided earnings guidance for the first quarter and full year 2026. For the first quarter, the company expects revenue of $20.5 million to $21.5 million. For the year, the company expects revenue of $89.0 million to $93.0 million.
分析記事 • Nov 07Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsShareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...
お知らせ • Nov 05+ 1 more updateArteris, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Arteris, Inc. provided earnings guidance for the fourth quarter of 2025. For the fourth quarter of 2025, the company expects revenue of $18.4 million to $18.8 million.
お知らせ • Aug 07Arteris, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the third quarter and full year 2025. For the quarter, the company expects revenue of $16.8 million to $17.2 million. For the year, the company expects revenue of $66.0 million to $70.0 million.
分析記事 • May 15Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...
お知らせ • May 15Arteris, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the second quarter and full year 2025. For the quarter, the company expects revenue of $16.1 million to $16.5 million. For the year, the company expects revenue of $65.0 million to $71.0 million.
お知らせ • May 14+ 1 more updateArteris, Inc. Announces Retirement of Nicholas B. Hawkins as Chief Financial Officer, Effective August 31, 2026Arteris, Inc. announced that on May 8, 2026, Nicholas B. Hawkins, Chief Financial Officer of Arteris, notified Arteris he will retire effective August 31, 2026. Mr. Hawkins will continue to serve as an advisor to the Company after his retirement date to facilitate an orderly transition. Mr. Hawkins’ decision to retire is due to an illness in his family and is not the result of any disagreement with the Company or its independent registered public accountants on any matter relating to the Company’s financial statements, operations, policies or practices. The Board of Directors of Arteris has initiated a comprehensive search for a new CFO.
ライブニュース • May 13Arteris Q1 2026 Revenue Tops Estimates With Cycuity Deal and CFO TransitionArteris reported Q1 2026 revenue of US$22.94 million, 39% higher year over year and about 8.7% above consensus estimates. The company closed the acquisition of Cycuity for US$43.1 million, adding hardware security verification software to its portfolio and contributing to integration-related costs in the quarter. Annual contract value and royalties reached a record US$92.8 million, with contracted future revenue of US$84.9 million as of March 31, 2026, while CFO Nicholas B. Hawkins plans to retire on August 31, 2026. This combination of strong reported revenue, record contract value and the Cycuity acquisition indicates a business focused on building a larger, recurring revenue base, alongside some near-term cost pressure from integration. Investors may want to watch how the upcoming CFO transition and the integration of Cycuity affect execution toward the company’s guidance for revenue growth, improved profitability and a move to positive free cash flow in 2026.
ナラティブの更新 • May 04AIP: Elevated Future P/E Assumptions Will Likely Constrain Forward Return PotentialAnalysts have increased their price target on Arteris by $0.25 to $20.50 as they refresh their assumptions around the discount rate, profit margin, revenue growth and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the refreshed assumptions on discount rate, profit margin, revenue growth and future P/E expectations as supportive of a higher valuation ceiling, which is reflected in the recent price target updates.
ナラティブの更新 • Apr 23Arteris Inc. – Collaboration with MIPS to Accelerate Physical AI SoC Platforms Arteris Inc. has announced a strategic collaboration with MIPS, a subsidiary of GlobalFoundries, to accelerate the development of next-generation system-on-chip (SoC) platforms tailored for physical AI applications.
お知らせ • Apr 22+ 1 more updateArteris, Inc., Annual General Meeting, Jun 02, 2026Arteris, Inc., Annual General Meeting, Jun 02, 2026.
ナラティブの更新 • Apr 19AIP: Elevated Multiple And Margin Uncertainty Will Constrain AI Era UpsideAnalysts have raised their Arteris price target by $3, citing updated assumptions around discount rates, revenue growth, profit margin, and future P/E that are reflected in the latest valuation model. Analyst Commentary Bearish analysts are treating the higher Arteris price target as a balance between long term potential and near term execution risk.
ナラティブの更新 • Apr 05AIP: AI Era Chip Adoption Will Support Continued Fair Value UpsideAnalysts kept their Arteris fair value estimate steady at $24.00, and modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E underpin a slightly refined but unchanged price target view. Analyst Commentary Recent Street research on Arteris points to a cluster of optimistic views, with bullish analysts adjusting price targets and sharpening their focus on the company’s execution and growth potential.
ナラティブの更新 • Mar 21AIP: AI Era Chip Demand And Execution Risks Will Shape Balanced OutlookAnalysts have lifted their price target on Arteris to $16.00 from $15.00, citing updated views on revenue growth, profit margins, and future P/E expectations. Analyst Commentary While the latest price target move reflects a more constructive view on Arteris, some bearish analysts are still flagging risks around execution and how the market is pricing the stock.
ナラティブの更新 • Mar 07AIP: AI Era Chip Adoption Will Drive Stronger Prospects AheadAnalysts have raised their price target on Arteris from $16.00 to $24.00, citing updated assumptions around revenue growth, profitability, discount rates and future P/E that they believe better reflect the company’s prospects. Analyst Commentary Recent Street research around Arteris highlights a clear tilt toward more optimistic assumptions on the stock, as reflected in higher price targets that analysts view as better aligned with their updated models on revenue, profitability and valuation multiples.
ナラティブの更新 • Feb 21AIP: Index Addition And Expanding Design Wins Will Likely Support UpsideAnalysts have raised their Arteris price target by $1 to $20.25, citing updates to revenue growth assumptions, profit margin outlook, discount rate inputs, and future P/E estimates reflected in recent Street research. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the higher price target to $20.25 reflects refreshed assumptions on revenue growth and profitability, which they see as better aligned with recent Street modeling.
お知らせ • Feb 13Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026Arteris, Inc. provided earnings guidance for the first quarter and full year 2026. For the first quarter, the company expects revenue of $20.5 million to $21.5 million. For the year, the company expects revenue of $89.0 million to $93.0 million.
ナラティブの更新 • Feb 07AIP: Index Inclusion And AI IP Wins Will Support Balanced OutlookAnalysts are keeping their fair value estimate for Arteris steady at $15.00, pointing to small tweaks in assumptions around discount rates, revenue growth, profit margins, and future P/E that fine tune rather than materially shift their outlook. What's in the News Arteris, Inc.
分析記事 • Feb 04Arteris, Inc.'s (NASDAQ:AIP) Intrinsic Value Is Potentially 25% Below Its Share PriceKey Insights Using the 2 Stage Free Cash Flow to Equity, Arteris fair value estimate is US$10.94 Arteris is estimated...
お知らせ • Feb 03Arteris, Inc. to Report Q4, 2025 Results on Feb 12, 2026Arteris, Inc. announced that they will report Q4, 2025 results After-Market on Feb 12, 2026
ナラティブの更新 • Jan 24AIP: Index Inclusion And New Design Wins Will Likely Unlock UpsideAnalysts have raised their fair value estimate for Arteris from US$17.13 to US$19.25, citing updated assumptions on revenue growth, profit margins and future P/E that they view as better aligned with the company’s current risk profile. What's in the News Arteris, Inc.
ナラティブの更新 • Jan 17Arteris, Inc. (NASDAQ: AIP) – Acquisition of Cycuity Strengthens Position in Semiconductor Cybersecurity for the AI EraAuthor: Qudus Adebara (Founder of Wane Investment House) Executive Summary Arteris, Inc. (“Arteris” or “the Company”), a leading provider of system IP for accelerating semiconductor development in the AI era, has closed its acquisition of Cycuity, Inc.
ナラティブの更新 • Jan 09AIP: Index Addition And AI IP Wins Will Mask Overvaluation RiskAnalysts maintained their fair value estimate for Arteris at $15.00, making only modest adjustments to assumptions on discount rate, revenue growth, profit margin, and future P/E to support this stable price target. What's in the News Arteris, Inc.
ナラティブの更新 • Dec 25AIP: Index Addition And AI Deals Will Support Balanced Long-Term OutlookAnalysts have raised their fair value estimate for Arteris from 11.00 dollars to 15.00 dollars, citing slightly stronger long term revenue growth expectations and an increased future earnings multiple, despite a modestly lower profit margin outlook. What's in the News Added to the S&P Software and Services Select Industry Index, increasing visibility among institutional investors (Index Constituent Adds).
お知らせ • Dec 13Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million.Arteris, Inc. (NasdaqGM:AIP) entered into an definitive agreement to acquire Cycuity, Inc. for $45 million on December 10, 2025. The consideration of $45 million will be paid as $13.5 million in cash and $19.5 million in shares of Arteris's common stock, par value $0.001 per share. The number of shares to be issued will be based on the volume-weighted average price (VWAP) of the Company’s common stock for the 30 consecutive trading days preceding the second trading day prior to the closing date, subject to a collar mechanism. In addition, there is an Earnout Consideration of up to an additional $12 million payable in shares of the Arteris’s common stock (converted at the VWAP), contingent upon Cycuity achieving certain specified bookings milestones for the 2026 calendar year. Arteris has entered into an Open Market Sale Agreement to offer and sell shares of its common stock, with a par value of $0.001 per share, having an aggregate offering price of up to $75 million. The net proceeds, if any, from these offering are intended to be used for general corporate purposes, including acquisitions or other strategic transactions, including acquisition of Cycuity, Inc. The transaction is subject to the approval of the Merger Agreement by Cycuity’s stockholders and other customary closing conditions. The transaction is expected to close in Arteris’ first quarter of fiscal year 2026. John M. Tolpa of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP acted as legal advisor for Cycuity, Inc. John A Fisher and Phillip Stoup of Freshfields US LLP acted as legal advisor for Arteris, Inc.
お知らせ • Dec 12Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.Arteris, Inc. has filed a Follow-on Equity Offering in the amount of $75 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
分析記事 • Dec 12Arteris, Inc. (NASDAQ:AIP) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 27% in the...
ナラティブの更新 • Dec 11AIP: Expanded AI Wins Will Likely Fail To Justify Rich ExpectationsAnalysts have modestly raised their price target on Arteris to approximately $17.13 per share. This reflects slightly higher long term margin expectations and a marginally improved growth and risk profile.
分析記事 • Nov 29Why Arteris, Inc. (NASDAQ:AIP) Could Be Worth WatchingWhile Arteris, Inc. ( NASDAQ:AIP ) might not have the largest market cap around , it led the NASDAQGM gainers with a...
ナラティブの更新 • Nov 27AIP: Major Platform Wins Will Drive Stronger Revenue And Margin UpsideAnalysts have raised their price target for Arteris from $16.75 to $17.13, citing slight improvements in fair value estimates along with modest adjustments in discount rate and profit margin assumptions. What's in the News Blaize adopted Arteris' FlexNoC 5 interconnect IP to enhance the performance and scalability of its programmable AI platform, enabling better energy efficiency and faster time-to-market for edge and cloud AI applications (Client Announcements).
Seeking Alpha • Nov 27Arteris: The Hidden Gem Powering The Chiplet RevolutionSummary Arteris is well-positioned in the semiconductor industry, leveraging its FlexNoC 5 and NCore technologies to address chiplet and interconnect complexity. Arteris' strong recurring revenue growth, high gross margins, and recent positive free cash flow signal improving financial health and operational efficiency. Valuation remains attractive, with shares trading below peers and a calculated fair value of $17 per share, offering potential upside from current levels. I rate Arteris stock a buy, recommending a portfolio allocation below 5% due to China exposure and customer concentration risks. Read the full article on Seeking Alpha
ナラティブの更新 • Nov 12AIP: Revenue Momentum And Client Wins Will Support Balanced OutlookAnalysts have raised their price target for Arteris from $15.00 to $16.75, citing improved revenue growth estimates and slight enhancements to profit margin expectations. What's in the News Blaize has adopted Arteris FlexNoC 5 interconnect IP to enhance the performance and scalability of its AI Platform for hybrid edge and cloud deployments (Client Announcements).
分析記事 • Nov 07Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsShareholders of Arteris, Inc. ( NASDAQ:AIP ) will be pleased this week, given that the stock price is up 12% to...
お知らせ • Nov 05+ 1 more updateArteris, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Arteris, Inc. provided earnings guidance for the fourth quarter of 2025. For the fourth quarter of 2025, the company expects revenue of $18.4 million to $18.8 million.
ナラティブの更新 • Oct 29Broader Partnerships And AI Adoption Will Shape Future Enterprise DemandAnalysts have raised their price target for Arteris by $1, from $14 to $15. They cited adjustments in growth and profitability expectations, despite a modest reduction in projected revenue growth and profit margins.
分析記事 • Oct 28Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 48%Arteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...
お知らせ • Oct 24Arteris, Inc. to Report Q3, 2025 Results on Nov 04, 2025Arteris, Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025
分析記事 • Sep 05Risks Still Elevated At These Prices As Arteris, Inc. (NASDAQ:AIP) Shares Dive 32%The Arteris, Inc. ( NASDAQ:AIP ) share price has softened a substantial 32% over the previous 30 days, handing back...
ナラティブの更新 • Aug 08AI And Chiplet Trends Will Expand Enterprise MarketsWith both the discount rate and future P/E multiples remaining virtually unchanged, Arteris’ consensus analyst price target also held steady at $14.00. What's in the News Arteris provided updated revenue guidance for Q3 2025 of $16.8–$17.2 million and full year 2025 of $66.0–$70.0 million.
お知らせ • Aug 07Arteris, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the third quarter and full year 2025. For the quarter, the company expects revenue of $16.8 million to $17.2 million. For the year, the company expects revenue of $66.0 million to $70.0 million.
分析記事 • Aug 06Estimating The Intrinsic Value Of Arteris, Inc. (NASDAQ:AIP)NasdaqGM:AIP 1 Year Share Price vs Fair Value Explore Arteris's Fair Values from the Community and select yours Key...
お知らせ • Jul 24Arteris, Inc. to Report Q2, 2025 Results on Aug 05, 2025Arteris, Inc. announced that they will report Q2, 2025 results on Aug 05, 2025
お知らせ • Jun 24Arteris, Inc. Addresses Silicon Design Reuse Challenge with New Magillem Packaging Product for Ip Blocks and ChipletsArteris, Inc. announced the immediate availability of Magillem Packaging, a new software product designed to simplify and speed up the process of building advanced chips used in everything from AI data centers to edge devices. As chip design becomes increasingly complex with more components, higher performance demands and tighter timelines, Magillem Packaging helps engineering teams work faster and more efficiently by automating one of the most time-consuming parts of the design process: assembling and reusing existing technology. Magillem Packaging enables IP teams to quickly and reliably package and prepare hundreds or even thousands of components for integration into a chiplet or SoC, including new, existing or third-party IP blocks. Based on the latest version of the IEEE 1685 (IP-XACT) standard, Magillem Packaging works seamlessly with industry tools and silicon IP, helping companies keep up with increasing design demands while reducing costly errors and delays. Key Capabilities of Magillem Packaging from Arteris: IP Reuse with comprehensive IP, subsystem and chiplet packaging in a reusable format including configuration, implementation and verification for incremental and full packaging with a proven methodology. Correct-by-construction IEEE 1685-2022 generation without requiring any pre- requisite IP-XACT expertise, while standard compliance and data consistency are ensured by construction and assessed with a built-in Magillem checkers suite. Scalable and fully automated generation of IP packaging for both reused and new IP blocks, with support for legacy 2009 and 2014 versions of IEEE 1685 standard, with intuitive graphical editors enabling fast viewing and editing of IP block descriptions. The new software builds on Arteris' proven approach to design automation and complements its broader suite of products used by many of the world's top semiconductor companies.
分析記事 • Jun 20Is It Time To Consider Buying Arteris, Inc. (NASDAQ:AIP)?Arteris, Inc. ( NASDAQ:AIP ), might not be a large cap stock, but it led the NASDAQGM gainers with a relatively large...
分析記事 • Jun 20Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 25%Arteris, Inc. ( NASDAQ:AIP ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
分析記事 • May 15Arteris, Inc. (NASDAQ:AIP) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Arteris, Inc. ( NASDAQ:AIP ) had a good week, as its shares rose 3.7% to close at US$7.51 following the...
お知らせ • May 15Arteris, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2025Arteris, Inc. provided revenue guidance for the second quarter and full year 2025. For the quarter, the company expects revenue of $16.1 million to $16.5 million. For the year, the company expects revenue of $65.0 million to $71.0 million.
お知らせ • Apr 25Arteris, Inc., Annual General Meeting, Jun 03, 2025Arteris, Inc., Annual General Meeting, Jun 03, 2025.
お知らせ • Apr 24Arteris, Inc. to Report Q1, 2025 Results on May 13, 2025Arteris, Inc. announced that they will report Q1, 2025 results After-Market on May 13, 2025
分析記事 • Apr 19Market Cool On Arteris, Inc.'s (NASDAQ:AIP) Revenues Pushing Shares 26% LowerTo the annoyance of some shareholders, Arteris, Inc. ( NASDAQ:AIP ) shares are down a considerable 26% in the last...
新しいナラティブ • Mar 28Semiconductor IP And FlexGen Systems Will Expand AI Automotive Markets Growing demand for AI and automotive solutions, alongside strategic microcontroller expansion, is set to drive Arteris' revenue and earnings growth.
分析記事 • Feb 26Some Confidence Is Lacking In Arteris, Inc. (NASDAQ:AIP) As Shares Slide 26%Arteris, Inc. ( NASDAQ:AIP ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...
お知らせ • Feb 26Arteris, Inc. Releases the Latest Generation of Magillem Registers to Automate Semiconductor Hardware/Software IntegrationArteris, Inc. announced the immediate availability of the latest generation of Magillem Registers technology for SoC integration automation. This product enables design teams to automate the hardware/software integration process, reducing the development time by 35% when compared to in-house solutions and empowers them to overcome design complexity challenges, freeing up cycles for new innovation.Magillem Registers is a comprehensive register design and management product that accurately automates the hardware/software interface (HSI) to quickly develop chips and chiplets ranging from IoT devices to complex AI datacenter multi-die SoCs. This product empowers chip architects, hardware designers, firmware engineers, verification teams, and documentation teams to overcome complexity and satisfy the need for real-time, effective cross-functional team communication. It mitigates the risk of out-of-date standards with a unified specification and compilation flow to generate accurate designs. Building upon the silicon-proven Magillem 5 and CSRCompiler technologies, the latest release of Magillem Registers is designed to streamline and optimize workflows by providing an integrated, single source of truth infrastructure to specify, document, implement, and verify SoC address maps. This approach boosts productivity by promoting efficient IP reuse and ensuring consistency across the relevant design teams. With over 1,000 semantic and syntactic checks, Magillem Registers ensures high-quality output, validating third-party IPs, in-house IPs, and overall system integration to significantly reduce the risk of silicon failure. Additionally, intelligent automation enables a remarkable 35%-time reduction in HSI development compared to manual solutions, empowering development teams to meet tight deadlines with confidence. The latest release of Magillem Registers brings significant advancements to performance, capacity, standards support, and usability. It delivers up to 3x faster performance compared to Magillem 5, enabling the compilation of million of registers within minutes while auto-generating synthesizable RTL register banks. With a 5x increase in supported design size, it scales seamlessly from small to very large multi-die devices which contain million of control registers. Magillem Registers offers broad support for industry standards, including the addition of IEEE 1685-2022 (IP-XACT) and SystemRDL 2.0, alongside the previous versions. This enhances intellectual property (IP) reuse, and expands compatibility with third-party IP vendors, improving SoC integration. Usability enhancements further boost team productivity with a rapid, highly iterative design environment incorporating features for streamlined input, intuitive document navigation, customizable workflows, and the elimination of repetitive time-consuming and error-prone manual tasks through advanced automation. Magillem Registers addresses the growing demands of modern design environments with unmatched efficiency and scalability.
Seeking Alpha • Feb 24Arteris Q4: Long Growth Runway Ahead Overshadowed By The Lack Of ProfitabilitySummary Management has guided for 15% year over year ACV plus Royalties, with corresponding growth in RPO of 22%. While the company, Arteris, remains unprofitable, margins are projected to improve, with positive FCF expected in 2025. At 4.5 times ACV plus Royalties, its valuation represents a significant discount compared to larger peers. Given its higher risk profile, I recommend AIP stock as a speculative Buy. Read the full article on Seeking Alpha
分析記事 • Feb 21Arteris, Inc. (NASDAQ:AIP) Analysts Are Pretty Bullish On The Stock After Recent ResultsArteris, Inc. ( NASDAQ:AIP ) came out with its full-year results last week, and we wanted to see how the business is...
お知らせ • Feb 19Arteris, Inc. Introduces FlexGen, Revolutionizing Semiconductor Design with Smart Network-on-Chip IPArteris, Inc. introduced FlexGen, a revolutionary, smart network-on-chip (NoC) interconnect IP. FlexGen from Arteris dramatically accelerates chip development while optimizing performance efficiency, addressing the rising demand for faster, more sustainable innovation in automotive, datacenter, consumer electronics, communications and industrial applications. With up to a 10x productivity boost, FlexGen slashes design iterations, significantly reducing the time required to develop cutting-edge chips. FlexGen also achieves up to a 30% reduction in wire length to lower power use, and up to 10% reduction in latency that results in improved performance in SoC and chiplet designs. FlexGen builds upon the silicon-proven and physically aware FlexNoC 5 NoC IP technology and component library to automate the creation of high-performance network-on-chip (NoC) designs. Supported by AI-driven automation, FlexGen reduces manual adjustments by over 90%, enabling the generation of optimized NoC topologies in hours instead of days. This significantly accelerates development while maintaining the quality achieved through manual methods. These advancements are critical as the industry scales to meet the demands of advanced technologies like artificial intelligence, autonomous driving and cloud computing. By streamlining chip design workflows and automating key processes, FlexGen enables companies to tackle the growing complexity of semiconductor design with fewer resources, paving the way for innovations in AI, 5G, and industrial IoT. With FlexGen, Arteris continues to revolutionize SoC and chiplet design automation based on Arm, RISC-V and x86 processors, enhancing productivity and positioning teams to address the complexities of next-generation electronic systems.
お知らせ • Feb 03Arteris, Inc. to Report Q4, 2024 Results on Feb 18, 2025Arteris, Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025
分析記事 • Dec 28Is Arteris (NASDAQ:AIP) Using Debt Sensibly?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Dec 01Arteris, Inc. (NASDAQ:AIP) Stock Rockets 26% As Investors Are Less Pessimistic Than ExpectedArteris, Inc. ( NASDAQ:AIP ) shareholders would be excited to see that the share price has had a great month, posting a...
お知らせ • Nov 06Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2024Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2024. For the quarter, the company expects revenue of $14.7 million - $15.7 million. For the year, the company expects revenue of $56.9 million - $57.9 million.
お知らせ • Oct 22Arteris, Inc. to Report Q3, 2024 Results on Nov 05, 2024Arteris, Inc. announced that they will report Q3, 2024 results After-Market on Nov 05, 2024
お知らせ • Oct 16Arteris Network-on-Chip Tiling Innovation Accelerates Semiconductor Designs for AI ApplicationsArteris, Inc. announced an innovative evolution of its network-on-chip (NoC) IP products with tiling capabilities and extended mesh topology support for faster development of Artificial Intelligence (AI) and Machine Learning (ML) compute in system-on-chip (SoC) designs. The new functionality enables design teams to scale compute performance by more than 10 times while meeting project schedules plus power, performance and area (PPA) goals. Network-on-chip tiling is an emerging trend in SoC design. The evolutionary approach uses proven, robust network-on-chip IP to facilitate scaling, condense design time, speed testing and reduce design risk. It allows SoC architects to create modular, scalable designs by replicating soft tiles across the chip. Each soft tile represents a self-contained functional unit, enabling faster integration, verification and optimization. Tiling coupled with mesh topologies within Arteris’ NoC IP products, FlexNoC and Ncore, are transformative for the ever-growing inclusion of AI compute into most SoCs. AI-enabled systems are growing in size and complexity yet can be quickly scaled with the addition of soft tiles without disrupting the entire SoC design. Together, the combination of tiling and mesh topologies provides a way to further reduce the auxiliary processing unit (XPU) sub-system design time and overall SoC connectivity execution time by up to 50% versus manually integrated, non-tiled designs. The first iteration of NoC tiling organizes Network Interface Units (NIUs) into modular, repeatable blocks, improving scalability, efficiency and reliability in SoC designs. These SoC designs result in increasingly larger and more advanced AI compute which supports fast-growing, sophisticated AI workloads for Vision, Machine Learning (ML) models, Deep Learning (DL), Natural Language Processing (NLP) including Large Language Models (LLMs), and Generative AI (GAI), both for training and inference, including at the edge. The FlexNoC and Ncore NoC IP products, which offer expanded AI support via tiling and extended mesh topology capabilities, are now available to early-access customers and partners.
Seeking Alpha • Oct 13Arteris: Favorable Industry Trends Set To Fuel Growth AheadSummary The company is poised to benefit from industry tailwinds arising from AI and autonomous driving, owing to its strong technology offering. Growth is strong, with the business already generating positive FCF so far this year. I expect mid double-digit growth rates to continue in the coming years, with an inflection to non-GAAP profitability likely next year. While risks are significant, the appealing valuation leads me to rate the shares as a speculative Buy. Read the full article on Seeking Alpha
お知らせ • Sep 17Joachim Kunkel Joins Arteris's Board of DirectorsArteris, Inc. announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys’ IP revenue to over $1.5 billion. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where he played a pivotal role in its early success by contributing to engineering, sales and marketing. He holds a master’s degree in electrical engineering from Aachen University of Technology, where he focused his research on system-level simulation techniques for digital signal processing.
お知らせ • Aug 02Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024Arteris, Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, the company expects revenue of $14.2 million to $15.2 million. For the year, the company expects revenue of $56.0million to $58.0 million.
分析記事 • Jul 27What Arteris, Inc.'s (NASDAQ:AIP) 26% Share Price Gain Is Not Telling YouDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 26% in the...
お知らせ • Jul 23Arteris, Inc. to Report Q2, 2024 Results on Aug 01, 2024Arteris, Inc. announced that they will report Q2, 2024 results After-Market on Aug 01, 2024
分析記事 • May 07Revenues Not Telling The Story For Arteris, Inc. (NASDAQ:AIP) After Shares Rise 32%Arteris, Inc. ( NASDAQ:AIP ) shares have continued their recent momentum with a 32% gain in the last month alone. The...
Recent Insider Transactions Derivative • May 06VP, General Counsel & Secretary exercised options and sold US$66k worth of stockOn the 1st of May, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$6.38 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$977k more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • May 03First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: US$0.25 loss per share. Revenue: US$12.9m (down 1.6% from 1Q 2023). Net loss: US$9.40m (loss widened 4.4% from 1Q 2023). Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US.
お知らせ • May 03Arteris, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024Arteris, Inc. provided earnings guidance for the Second Quarter and Full Year 2024. For the quarter, the company expected ACV + TTM royalties to be $58.0 million - $62.0 million. Revenue to be $13.2 million - $14.2 million. For the year, the company expected ACV + TTM royalties to be $62.0 million - $68.0 million. Revenue to be $54.5 million - $57.5 million.
お知らせ • Apr 24+ 1 more updateArteris, Inc., Annual General Meeting, Jun 04, 2024Arteris, Inc., Annual General Meeting, Jun 04, 2024, at 08:30 Pacific Standard Time. Agenda: To consider election of Class III directors whose current terms will expire at the annual meeting of stockholders to be held in 2024; to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm and independent auditor for the fiscal year ending December 31, 2024; and to consider transact any other business as may properly come before the 2024 Annual Meeting or any adjournments or postponement thereof.
Recent Insider Transactions • Apr 07Chairman recently sold US$71k worth of stockOn the 2nd of April, Karel Janac sold around 10k shares on-market at roughly US$7.03 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karel has been a net seller over the last 12 months, reducing personal holdings by US$106k.
Recent Insider Transactions Derivative • Apr 05VP, General Counsel & Secretary exercised options and sold US$75k worth of stockOn the 1st of April, Paul Alpern exercised 11k options at a strike price of around US$0.56 and sold these shares for an average price of US$7.24 per share. This trade did not impact their existing holding. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$764k more than they bought, via options and on-market transactions in the last 12 months.
お知らせ • Mar 13Arteris Expands Ncore Cache Coherent Interconnect IP to Accelerate Leading-Edge Electronics DesignsArteris, Inc. announced the immediate availability of the latest release of Ncore cache coherent network-on-chip (NoC) IP. Ncore ensures low latency integration of hardware accelerators into a coherent domain, enabling the speed and efficiency required for cutting-edge applications in complex SoC designs. Deploying Ncore can save SoC design teams upwards of 50 years of engineering effort per project compared to manually generated interconnect solutions. The latest release of Ncore works with multiple processor IPs, including RISC-V and the next-generation Armv9 Cortex processor IP. Ncore boasts multi-protocol support, allowing seamless integration of IPs connected to the same NoC fabric. Designers can choose from CHI-E, CHI-B and ACE fully coherent agent interfaces and ACE-Lite IO-coherent interfaces. AXI is also supported for interfacing with sub-systems or devices without coherency requirements. These capabilities enhance the flexibility and adaptability of Ncore, making it an ideal solution for complex and evolving SoC designs, including safety-critical applications. With configurability and scalability at its core, Ncore empowers SoC designers to meet specific power, performance and area requirements with the flexible fine-tuning of the NoC architecture. Ncore is also ISO 26262 certified, helping design teams address the critical demands of automotive and industrial safety applications with requirements from ASIL B to ASIL D. Ncore's ISO 26262 certification underscores Arteris' ongoing commitment to delivering safe, secure and reliable technology to its global customers. Ncore supports direct connections for heterogeneous, asymmetric systems and other flexible connectivity options, ensuring adaptability to various applications across automotive, industrial, communications and enterprise computing markets. Ncore cache coherent interconnect IP is an ideal companion to FlexNoC, Arteris' industry-leading non-coherent interconnect IP.
Recent Insider Transactions Derivative • Mar 08VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 12k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of March. If the sale is conducted around the recent share price of US$7.26, it would amount to US$84k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$595k more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Feb 22Full year 2023 earnings: EPS in line with analyst expectations despite revenue beatFull year 2023 results: US$1.03 loss per share (further deteriorated from US$0.84 loss in FY 2022). Revenue: US$53.7m (up 6.5% from FY 2022). Net loss: US$36.9m (loss widened 35% from FY 2022). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Software industry in the US.
お知らせ • Feb 21Arteris, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024Arteris, Inc. provided earnings guidance for the first quarter and full year of 2024. For the quarter, the company expects revenue of $12.1 million to $13.1 million.For the year, the company expects revenue of $54.5 million to $57.5 million.
分析記事 • Feb 09Optimistic Investors Push Arteris, Inc. (NASDAQ:AIP) Shares Up 29% But Growth Is LackingDespite an already strong run, Arteris, Inc. ( NASDAQ:AIP ) shares have been powering on, with a gain of 29% in the...
Recent Insider Transactions Derivative • Feb 04VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 13k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of February. If the sale is conducted around the recent share price of US$6.19, it would amount to US$82k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 0. Company insiders have collectively sold US$532k more than they bought, via options and on-market transactions in the last 12 months.
Board Change • Feb 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent Director Claudia Munce was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 30Arteris, Inc. to Report Q4, 2023 Results on Feb 20, 2024Arteris, Inc. announced that they will report Q4, 2023 results After-Market on Feb 20, 2024
Recent Insider Transactions Derivative • Jan 07VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 32k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of January. If the sale is conducted around the recent share price of US$5.41, it would amount to US$174k. Since March 2023, Nicholas' direct individual holding has decreased from 269.10k shares to 189.10k. Company insiders have collectively sold US$427k more than they bought, via options and on-market transactions in the last 12 months.
分析記事 • Dec 14Subdued Growth No Barrier To Arteris, Inc. (NASDAQ:AIP) With Shares Advancing 39%Arteris, Inc. ( NASDAQ:AIP ) shareholders are no doubt pleased to see that the share price has bounced 39% in the last...
Recent Insider Transactions Derivative • Dec 07VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 21k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of December. If the sale is conducted around the recent share price of US$5.40, it would amount to US$112k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 209.10k. Company insiders have collectively sold US$370k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Nov 26VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of November. If the sale is conducted around the recent share price of US$4.80, it would amount to US$96k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 229.10k. Company insiders have collectively sold US$313k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Nov 18VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 53k shares in the next 90 days after lodging an Intent To Sell Form on the 15th of November. If the sale is conducted around the recent share price of US$4.86, it would amount to US$258k. Since June 2023, Paul's direct individual holding has decreased from 46.90k shares to 43.07k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Nov 10Third quarter 2023 earnings: EPS and revenues exceed analyst expectationsThird quarter 2023 results: US$0.23 loss per share. Revenue: US$13.3m (up 5.4% from 3Q 2022). Net loss: US$8.15m (loss widened 6.1% from 3Q 2022). Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US.
分析記事 • Nov 09Downgrade: Here's How Analysts See Arteris, Inc. (NASDAQ:AIP) Performing In The Near TermOne thing we could say about the analysts on Arteris, Inc. ( NASDAQ:AIP ) - they aren't optimistic, having just made a...
お知らせ • Nov 09Arteris, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023Arteris, Inc. provided revenue guidance for the fourth quarter and full year 2023. For the quarter, the company expected revenue to be in the range of $11.3 million to $12.3 million. For the full year, the company expected revenue to be in the range of $52.5 million to $53.5 million.
Price Target Changed • Nov 09Price target decreased by 18% to US$11.50Down from US$14.00, the current price target is an average from 6 analysts. New target price is 138% above last closing price of US$4.83. Stock is up 4.5% over the past year. The company is forecast to post a net loss per share of US$1.07 next year compared to a net loss per share of US$0.84 last year.
お知らせ • Oct 25Arteris, Inc. to Report Q3, 2023 Results on Nov 07, 2023Arteris, Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023
Recent Insider Transactions Derivative • Oct 06VP & CFO notifies of intention to sell stockNicholas Hawkins intends to sell 23k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of October. If the sale is conducted around the recent share price of US$6.24, it would amount to US$141k. Since December 2022, Nicholas' direct individual holding has decreased from 269.10k shares to 249.10k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions Derivative • Sep 11Chief Operating Officer notifies of intention to sell stockLaurent Moll intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of September. If the sale is conducted around the recent share price of US$7.19, it would amount to US$146k. Since December 2022, Laurent's direct individual holding has increased from 77.29k shares to 185.77k. Company insiders have collectively sold US$230k more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Aug 04Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.18 loss in 2Q 2022). Revenue: US$14.7m (flat on 2Q 2022). Net loss: US$9.17m (loss widened 62% from 2Q 2022). Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) missed analyst estimates by 5.4%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in the US.
お知らせ • Aug 04Arteris, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2023Arteris, Inc. provided earnings guidance for the third quarter and full year of 2023. For the quarter, the company expects revenue to be in the range of $12.5 million to $13.5 million.For the full year, the company expects revenue to be in the range of $54.0 million to $56.0 million.
お知らせ • Jul 23Arteris, Inc. to Report Q2, 2023 Results on Aug 03, 2023Arteris, Inc. announced that they will report Q2, 2023 results After-Market on Aug 03, 2023
Recent Insider Transactions Derivative • Jun 12VP, General Counsel & Secretary notifies of intention to sell stockPaul Alpern intends to sell 42k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of June. If the sale is conducted around the recent share price of US$7.44, it would amount to US$313k. Paul now holds 48.95k shares directly in their own name. Company insiders have collectively bought US$49k more than they sold, via options and on-market transactions, in the last 12 months.
お知らせ • May 06Arteris, Inc. Provides Earnings Guidance for the Second Quarter of 2023; Provides Earnings Guidance for the Year 2023Arteris, Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expects revenue of $53.5 million to $57.5 million.For the year, the company expects revenue of $60.4 million to $65.4 million.
Reported Earnings • May 06First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: US$0.26 loss per share (further deteriorated from US$0.22 loss in 1Q 2022). Revenue: US$13.2m (up 12% from 1Q 2022). Net loss: US$9.01m (loss widened 32% from 1Q 2022). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 9.6%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Software industry in the US.
Price Target Changed • Mar 14Price target decreased by 8.1% to US$13.60Down from US$14.80, the current price target is an average from 5 analysts. New target price is 202% above last closing price of US$4.51. Stock is down 65% over the past year. The company is forecast to post a net loss per share of US$0.93 next year compared to a net loss per share of US$0.84 last year.